- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 117
Daily deal net: September 1, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Sep 1, 2021Plaid plays to get Emotion Tech
Customer engagement management technology provider Plaid has become the major shareholder of a portfolio company that runs a similar service.
Sep 1, 2021Zeekr sees its way to $500m
Bilibili, CATL and Intel were among the investors that have backed the smart EV developer’s pre-series A round, valuing the Geely spinoff at $9bn.
Aug 31, 2021Daily deal net: August 31, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Aug 31, 2021Neural Galaxy taps into $77m series A
Harvard and MIT-linked Neural Galaxy has picked up $77m in a series A round led by existing shareholder 3E Bioventures.
Aug 31, 2021SenseTime feels its way toward public markets
Alibaba, Qualcomm, SoftBank, Suning and Dalian Wanda are among the investors that could exit the AI-equipped machine vision technology developer, most recently valued at $12bn.
Aug 31, 2021Doctor Anywhere gets administered series C funding
Novo and Philips Venture have joined existing investor IHH Healthcare in a $65.7m series C round for healthcare booking platform developer Doctor Anywhere.
Aug 31, 2021Daily Deal Round Up: August 27, 2021
Opt's Bonds Investment Group led interior design sharing platform RoomClip's series E round in addition to online learning platform developer Schoo's series D.
Aug 27, 2021Daily deal net: August 27, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Aug 27, 2021Genuine Biotech gets real with $100m
Shanghai Desano Pharmaceuticals has contributed to a series B round for the antiviral, cancer and cardiovascular drug developer, which is seeking to list in Hong Kong.
Aug 27, 2021About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


